Steady mild symptoms linked to independence in older cancer patients
Among 710 older adults with advanced cancer, 17.7% maintained mild symptoms over six months, a pattern linked to stable daily functioning.
6 months, registered NCT02054741
Limit: All 189 deaths counted as non-resilience, potentially biasing comparisons of symptom patterns and independence
Edited by Boris Djordjevic · AgingResearch.News
An observational analysis included 710 adults aged 70 and older with advanced cancer; their average age was 77.2, and 43.2% were female. They had at least one aging-related condition and were starting cancer treatment carrying a high risk of side effects. Most received chemotherapy.
Researchers assessed 24 patient-reported symptoms and independence in daily activities before treatment, at 4–6 weeks, three months and six months. They defined symptom resilience as maintaining or reaching no or mild symptoms. Only a consistently mild symptom pattern qualified in this analysis. That group began with higher independence scores: 13.2 versus 12.0 on a scale from 0 to 14. Scores remained stable in this group. Patients classified as non-resilient had declines of 0.7–0.9 points, without recovery by six months.
Why it matters
Cancer treatment in later life raises questions about maintaining independence as symptoms change. The authors called for research into factors behind resilient symptom responses to inform interventions that promote them.
Caveats
This secondary analysis used data from a cluster-randomized trial, but researchers grouped patients by modeled symptom patterns rather than randomly assigning resilience groups. All 189 deaths within six months counted as non-resilience; the findings concern older adults with advanced cancer and aging-related conditions.
The paper
University of Rochester
The Oncologist, Mar 22, 2026, Open access
